Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curtright

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Investigational New Drugs|January 24, 2007
A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomasQuincy S C Chu, Bahram Forouzesh, Samira Syed, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|August 21, 2010
Prioritizing environmental health risks in the UAEHenry H Willis, Jacqueline MacDonald Gibson, Regina A Shih, et al.
Health Services Management Research|October 30, 2008
Standardized care processes to improve quality and safety of patient care in a large academic practice: the Plummer Project of the Department of Medicine, Mayo ClinicDouglas L Wood, Michael D Brennan, Rajeev Chaudhry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Phase I and pharmacokinetic study of lapatinib in combination with capecitabine in patients with advanced solid malignanciesQuincy S C Chu, Garry Schwartz, Johann de Bono, et al.
Nature Methods|March 24, 2020
RecV recombinase system for in vivo targeted optogenomic modifications of single cells or cell populationsShenqin Yao, Peng Yuan, Ben Ouellette, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Investigational New Drugs|January 24, 2007
A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomasQuincy S C Chu, Bahram Forouzesh, Samira Syed, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|August 21, 2010
Prioritizing environmental health risks in the UAEHenry H Willis, Jacqueline MacDonald Gibson, Regina A Shih, et al.
Health Services Management Research|October 30, 2008
Standardized care processes to improve quality and safety of patient care in a large academic practice: the Plummer Project of the Department of Medicine, Mayo ClinicDouglas L Wood, Michael D Brennan, Rajeev Chaudhry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Phase I and pharmacokinetic study of lapatinib in combination with capecitabine in patients with advanced solid malignanciesQuincy S C Chu, Garry Schwartz, Johann de Bono, et al.
Nature Methods|March 24, 2020
RecV recombinase system for in vivo targeted optogenomic modifications of single cells or cell populationsShenqin Yao, Peng Yuan, Ben Ouellette, et al.
Pageof 3